The Managing Hodgkin Lymphoma Expert Interview Series

In this series, Dr. George Davatelis interviews various clinical experts from around the globe regarding clinical challenges they experience in their daily practice treating and managing patients with HL. This group of 12 interviews presented over the next year will address shared global needs in HL as well as specific needs prevalent in Europe, South America, and Asia.
Although many of the challenges faced by clinicians may be similar in these regions, nuances and differences in treatment approaches exist and are explored here. Some of the topics to be addressed are best practices in relapsed/refractory HL, combined modality treatment, the role of transplantation, the role of PET in guiding treatment decisions, the optimal number of chemotherapy cycles for each patient and the benefit of prognostic markers in tailoring treatment approaches. Stay tuned as we add additional interviews over the coming months.

• Europe • Asia
• South America • Global
Last modified: March 11, 2015

Managing HL would like to recognize and thank Merck & Co., Inc., Seattle Genetics, and Takeda Oncology for their educational support of ManagingHodgkinLymphoma.com

©2017 MediCom Worldwide, Inc. All rights reserved